Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss
Status:
Recruiting
Trial end date:
2022-08-30
Target enrollment:
Participant gender:
Summary
Primary objective of the study is to assess the efficacy of SENS-401 on hearing loss in
comparison to placebo at the end of the 4-week treatment period